On 29 April Legal Business launched its first summit focused on M&A and corporate transactions. The one-day event saw us team up with a host of leading firms including Latham & Watkins, Linklaters, Bristows and Greenberg Traurig to debate the key trends in the deal market in front of more than 150 delegates.
Is the job of the legal function to be the ringmaster and cheerleader, managing risk and compliance effectively within an organisation? Should it have to win over the hearts and minds of the board just as much as those on the front line? These were the main discussion points of a recent panel debate between …
The final session before lunch in our Corporate and M&A Summit looked at the mechanics of auctions and how best to handle the competitive bid process from both the buyer’s and seller’s perspective. The session, moderated by co-chair of Greenberg Traurig’s global corporate practice, Fiona Adams, brought together panellists experienced in the auction process. Joining …
It was fitting that one of the first morning sessions of our inaugural Corporate and M&A Summit dealt with arguably the trickiest period of any public M&A deal – the first week, and specifically critical initial dealings with the Takeover Panel. Introducing the topic, moderator Simon Wood from Addleshaw Goddard – who spent two years …
Continue reading “The Takeover Panel – that crucial first week”
A key morning session of our 2019 Corporate and M&A Summit saw Linklaters London competition head Nicole Kar chair a lively debate on competition law and policy and its effect on M&A. The panel of three featured economist Dr Claudio Calcagno, a vice president at Analysis Group and an expert in the competition arena, and …
Continue reading “Tougher competition – the growing impact of antitrust marquee deals”
Given that mega mergers coming out of the pharmaceutical and life sciences sector have dominated the corporate agenda for decades, it was fitting that an afternoon session of our inaugural Corporate and M&A Summit focused on transactional trends in this area. Chaired by Laura Anderson, co-chair of Bristows life sciences group, it gathered a collection …
Continue reading “Big pharma, small partners: the key transactional trends in life sciences”
One of the set-piece debates of day one of Enterprise GC covered a pressing issue for general counsel (GCs) – how to widen their skillset by gaining board experience, as well as practical tips on becoming a non-executive director (NED) in particular. The session, chaired by veteran City columnist James Ashton, featured some seasoned campaigners: …
Continue reading “Broader horizons – How GCs can secure those prized outside roles”
Mark McAteer, Legal Business: Is there much appetite within family offices to forum shop? And whose responsibility is it to make them aware of the options available? Jonathan Conder, Macfarlanes: If it is brand new, for sure. It is one of the first bits that we end up covering.
Mark McAteer, Legal Business: How are you feeling going into the next financial year? Nick Scott, Brodies: I am buoyed by the resilience of our clients.
A clear focus on a number of #MeToo episodes among City law firms has led to a close examination of culture by risk teams as well as wider discussion of reputational damage and the extent to which this can be measured. We gathered leading risk experts from some of the UK and international firms in …
Continue reading “Picking up the pieces – the risk debate gauges the #MeToo era”
